Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) Equity Average (2024 - 2025)

Allarity Therapeutics' Equity Average history spans 2 years, with the latest figure at $10.9 million for Q4 2025.

  • For Q4 2025, Equity Average fell 11.85% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $10.9 million, down 11.85%, while the annual FY2025 figure was $10.8 million, N/A changed from the prior year.
  • Equity Average reached $10.9 million in Q4 2025 per ALLR's latest filing, down from $12.1 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $16.4 million in Q3 2024 to a low of $6.7 million in Q2 2024.